LEXICON PHARMACEUTICALS, INC.

Nasdaq:LXRX

Pharmaceutical Preparations·THE WOODLANDS, TX

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company developing treatments for human disease.

CEO

Exton Michael

CFO

Coiante Scott M

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/5/26	→
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/6/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/7/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
↓

Earnings Releases (8-K)

25 shown

Filed	Period
3/5/26	Q1 FY2026	→
1/29/26	Q4 FY2026	→
11/6/25	Q4 FY2025	→
8/6/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/6/25	Q1 FY2025	→
↓

News (8-K)

55 shown

Filed	Type	Description
2/2/26	Agreement	Entry into a Material Definitive Agreement	→
11/10/25	Other	Other Events	→
11/6/25	Other	Other Events	→
7/28/25	Other	Other Events	→
7/3/25	Other	Other Events	→
6/3/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/6/26	FWP	FWP	→
2/2/26	424B5	424B5	→
1/30/26	FWP	FWP	→
1/30/26	FWP	FWP	→
1/29/26	424B5	424B5	→
11/6/25	424B5	424B5	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

10-K

Mar 5, 2026

0001062822-26-00005010-K

Dec 31, 2025

9.3 MB

8-K

Mar 5, 2026

0001062822-26-0000478-K

Mar 5, 2026

220.1 KB

Mar 3, 2026

0001062822-26-000041PRIMARY DOCUMENT

Feb 28, 2026

15.3 KB

Mar 3, 2026

0001062822-26-000040PRIMARY DOCUMENT

Feb 28, 2026

8.5 KB

Mar 3, 2026

0001062822-26-000039PRIMARY DOCUMENT

Feb 28, 2026

15.3 KB

Mar 3, 2026

0001062822-26-000038PRIMARY DOCUMENT

Feb 28, 2026

15.3 KB

Mar 3, 2026

0001062822-26-000037PRIMARY DOCUMENT

Feb 28, 2026

12.0 KB

Mar 3, 2026

0001062822-26-000036PRIMARY DOCUMENT

Feb 28, 2026

15.3 KB

Mar 3, 2026

0001062822-26-000035PRIMARY DOCUMENT

Feb 28, 2026

8.4 KB

Mar 3, 2026

0001062822-26-000034PRIMARY DOCUMENT

Feb 28, 2026

8.5 KB

Feb 27, 2026

0001062822-26-000033PRIMARY DOCUMENT

Feb 25, 2026

7.2 KB

Feb 25, 2026

0001062822-26-000032PRIMARY DOCUMENT

Feb 23, 2026

7.2 KB

Feb 23, 2026

0001062822-26-000031PRIMARY DOCUMENT

Feb 19, 2026

9.6 KB

Feb 19, 2026

0001193125-26-0595994

Feb 17, 2026

32.9 KB

Feb 18, 2026

0001062822-26-000029PRIMARY DOCUMENT

Feb 13, 2026

11.4 KB

PRE 14A

Feb 17, 2026

0001062822-26-000027PRE 14A

Feb 17, 2026

1.8 MB

Feb 17, 2026

0001062822-26-000026PRIMARY DOCUMENT

Feb 12, 2026

7.6 KB

Feb 17, 2026

0001062822-26-000025PRIMARY DOCUMENT

Feb 12, 2026

7.7 KB

Feb 17, 2026

0001062822-26-000024PRIMARY DOCUMENT

Feb 12, 2026

7.7 KB

Feb 17, 2026

0001062822-26-000023PRIMARY DOCUMENT

Feb 12, 2026

7.6 KB

Feb 17, 2026

0001062822-26-000022PRIMARY DOCUMENT

Feb 12, 2026

7.7 KB

Feb 17, 2026

0001062822-26-000021PRIMARY DOCUMENT

Feb 12, 2026

7.6 KB

Feb 17, 2026

0001062822-26-000020PRIMARY DOCUMENT

Feb 12, 2026

7.6 KB

Feb 17, 2026

0001062822-26-000019PRIMARY DOCUMENT

Feb 12, 2026

7.7 KB

Feb 17, 2026

0001193125-26-054545

—

18.4 KB

25 filings shown

Filed	Form	Description
2/17/26	D	D	→
2/2/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
7/8/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/12/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/15/24	EFFECT	EFFECT	→
8/15/24	144	144	→
↓

LEXICON PHARMACEUTICALS, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/3/26	4	PRIMARY DOCUMENT	→
3/3/26	4	PRIMARY DOCUMENT	→
3/3/26	4	PRIMARY DOCUMENT	→
3/3/26	4	PRIMARY DOCUMENT	→
3/3/26	4	PRIMARY DOCUMENT	→
3/3/26	4	PRIMARY DOCUMENT	→
↓